KURA Kura Oncology, Inc.

NASDAQ
$10.65

Kura Oncology, Inc. (KURA) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

30D 90D 6M 1Y
Insider signal In line Selling ran in line with KURA's own trailing one-year pace, with 38% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 1 buyer in the last 90 days 6 sellers in the last 90 days
Insiders buying
1
2 transactions
Insiders selling
7
40 transactions
Purchases
$2.4M
200,000 shares
Sales
$3.8M
368,073 shares
Net activity
-$1.5M
purchases less sales

How much of that selling was preplanned? 38% planned / 62% discretionary

10b5-1 plan sales $1.5M 8 transactions · 139,281 shares
Discretionary sales $2.4M 32 transactions · 228,792 shares

Largest single sale: $834.3K.

Where they traded

Buy Sell Dot area is proportional to transaction value.

Last open-market purchase: August 24, 2026 , by WILSON TROY EDWARD .

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Leoni Mollie Chief Medical Officer Sell 28,802 $10.75 $309.6K 141,095 −17% of holding
Powl Brian T. Chief Commercial Officer Sell 15,430 $10.75 $165.9K 136,819 −10.1% of holding
FORD KATHLEEN Chief Operating Officer Sell 10b5-1 3,668 $10.75 $39.4K 142,986 −2.5% of holding
Powl Brian T. 2 fills Chief Commercial Officer Sell 17,020 $10.53 $179.2K 160,249 −9.6% of holding
Leoni Mollie Chief Medical Officer Sell 12,448 $10.50 $130.7K 169,897 −6.8% of holding
Bair Teresa Brophy Chief Legal Officer Sell 8,442 $10.50 $88.6K 187,002 −4.3% of holding
FORD KATHLEEN Chief Operating Officer Sell 6,906 $10.50 $72.5K 146,654 −4.5% of holding
DOYLE THOMAS JAMES SVP, Finance & Accounting Sell 4,607 $10.50 $48.4K 142,428 −3.1% of holding
Burrows Francis Chief Scientific Officer Sell 20,726 $10.83 $224.5K 42,327 −32.9% of holding
WILSON TROY EDWARD President and CEO Buy 100,000 $12.39 $1.2M 479,194
Powl Brian T. Chief Commercial Officer Sell 10b5-1 4,345 $11.89 $51.7K 169,269 −2.5% of holding
Bair Teresa Brophy Chief Legal Officer Sell 10b5-1 31,487 $12.63 $397.7K 195,444 −13.9% of holding
WILSON TROY EDWARD President and CEO Buy 100,000 $11.12 $1.1M 379,194
Leoni Mollie Chief Medical Officer Sell 10b5-1 84,929 $9.82 $834.3K 182,345 −31.8% of holding
Powl Brian T. Chief Commercial Officer Sell 10b5-1 10,000 $11.00 $110.0K 173,614 −5.4% of holding
FORD KATHLEEN Chief Operating Officer Sell 10b5-1 2,257 $9.08 $20.5K 153,560 −1.4% of holding
Powl Brian T. Chief Commercial Officer Sell 10b5-1 339 $9.21 $3.1K 183,614 −0.2% of holding
Bair Teresa Brophy Chief Legal Officer Sell 10b5-1 2,256 $9.38 $21.2K 226,931 −1% of holding
Bair Teresa Brophy 3 fills Chief Legal Officer Sell 11,208 $8.46 $94.8K 234,043 −4.6% of holding
Leoni Mollie 4 fills Chief Medical Officer Sell 8,180 $8.46 $69.2K 271,799 −2.9% of holding
DOYLE THOMAS JAMES 5 fills SVP, Finance & Accounting Sell 7,142 $8.46 $60.4K 150,083 −4.5% of holding
Powl Brian T. 2 fills Chief Commercial Officer Sell 6,414 $8.46 $54.3K 184,847 −3.4% of holding
FORD KATHLEEN Chief Operating Officer Sell 1,813 $8.46 $15.3K 153,560 −1.2% of holding
Burrows Francis Chief Scientific Officer Sell 1,311 $8.46 $11.1K 32,424 −3.9% of holding
Burrows Francis Chief Scientific Officer Sell 23,726 $9.78 $231.9K 33,735 −41.3% of holding
Hasnain Faheem Director Sell 10,000 $10.98 $109.8K 23,983 −29.4% of holding
Leoni Mollie Chief Medical Officer Sell 15,485 $11.18 $173.1K 225,454 −6.4% of holding
Powl Brian T. Chief Commercial Officer Sell 8,887 $11.18 $99.3K 139,689 −6% of holding
Bair Teresa Brophy Chief Legal Officer Sell 8,804 $11.18 $98.4K 188,139 −4.5% of holding
FORD KATHLEEN Chief Operating Officer Sell 6,902 $11.18 $77.1K 105,373 −6.1% of holding
DOYLE THOMAS JAMES SVP, Finance & Accounting Sell 4,539 $11.18 $50.7K 130,257 −3.4% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.